137 related articles for article (PubMed ID: 17372273)
1. EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes.
Grandal MV; Zandi R; Pedersen MW; Willumsen BM; van Deurs B; Poulsen HS
Carcinogenesis; 2007 Jul; 28(7):1408-17. PubMed ID: 17372273
[TBL] [Abstract][Full Text] [Related]
2. A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling.
Waterman H; Katz M; Rubin C; Shtiegman K; Lavi S; Elson A; Jovin T; Yarden Y
EMBO J; 2002 Feb; 21(3):303-13. PubMed ID: 11823423
[TBL] [Abstract][Full Text] [Related]
3. Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis.
Duan L; Miura Y; Dimri M; Majumder B; Dodge IL; Reddi AL; Ghosh A; Fernandes N; Zhou P; Mullane-Robinson K; Rao N; Donoghue S; Rogers RA; Bowtell D; Naramura M; Gu H; Band V; Band H
J Biol Chem; 2003 Aug; 278(31):28950-60. PubMed ID: 12754251
[TBL] [Abstract][Full Text] [Related]
4. Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation.
Grøvdal LM; Stang E; Sorkin A; Madshus IH
Exp Cell Res; 2004 Nov; 300(2):388-95. PubMed ID: 15475003
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized.
Padrón D; Sato M; Shay JW; Gazdar AF; Minna JD; Roth MG
Cancer Res; 2007 Aug; 67(16):7695-702. PubMed ID: 17699773
[TBL] [Abstract][Full Text] [Related]
6. Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling.
Shtiegman K; Kochupurakkal BS; Zwang Y; Pines G; Starr A; Vexler A; Citri A; Katz M; Lavi S; Ben-Basat Y; Benjamin S; Corso S; Gan J; Yosef RB; Giordano S; Yarden Y
Oncogene; 2007 Oct; 26(49):6968-78. PubMed ID: 17486068
[TBL] [Abstract][Full Text] [Related]
7. Abi-1 forms an epidermal growth factor-inducible complex with Cbl: role in receptor endocytosis.
Tanos BE; Pendergast AM
Cell Signal; 2007 Jul; 19(7):1602-9. PubMed ID: 17395426
[TBL] [Abstract][Full Text] [Related]
8. Re-localization of activated EGF receptor and its signal transducers to multivesicular compartments downstream of early endosomes in response to EGF.
Oksvold MP; Skarpen E; Wierød L; Paulsen RE; Huitfeldt HS
Eur J Cell Biol; 2001 Apr; 80(4):285-94. PubMed ID: 11370743
[TBL] [Abstract][Full Text] [Related]
9. Grb2 mediates negative regulation of stem cell factor receptor/c-Kit signaling by recruitment of Cbl.
Sun J; Pedersen M; Bengtsson S; Rönnstrand L
Exp Cell Res; 2007 Nov; 313(18):3935-42. PubMed ID: 17904548
[TBL] [Abstract][Full Text] [Related]
10. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.
Timpson P; Lynch DK; Schramek D; Walker F; Daly RJ
Cancer Res; 2005 Apr; 65(8):3273-80. PubMed ID: 15833860
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody cetuximab binds to and down-regulates constitutively activated epidermal growth factor receptor vIII on the cell surface.
Patel D; Lahiji A; Patel S; Franklin M; Jimenez X; Hicklin DJ; Kang X
Anticancer Res; 2007; 27(5A):3355-66. PubMed ID: 17970081
[TBL] [Abstract][Full Text] [Related]
12. [Ubiquitination-mediated degradation of epidermal growth factor receptor].
Xiu X; Lü ZM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):120-7. PubMed ID: 15782507
[TBL] [Abstract][Full Text] [Related]
13. Endocytosis and intracellular trafficking of ErbBs.
Sorkin A; Goh LK
Exp Cell Res; 2008 Oct; 314(17):3093-106. PubMed ID: 18793634
[TBL] [Abstract][Full Text] [Related]
14. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.
Nishimura Y; Takiguchi S; Ito S; Itoh K
Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196
[TBL] [Abstract][Full Text] [Related]
15. EGFRvIII undergoes activation-dependent downregulation mediated by the Cbl proteins.
Davies GC; Ryan PE; Rahman L; Zajac-Kaye M; Lipkowitz S
Oncogene; 2006 Oct; 25(49):6497-509. PubMed ID: 16702950
[TBL] [Abstract][Full Text] [Related]
16. Gefitinib-sensitive EGFR lacking residues 746-750 exhibits hypophosphorylation at tyrosine residue 1045, hypoubiquitination, and impaired endocytosis.
Furukawa M; Nagatomo I; Kumagai T; Yamadori T; Takahashi R; Yoshimura M; Yoneda T; Takeda Y; Goya S; Matsuoka H; Kijima T; Yoshida M; Osaki T; Tachibana I; Greene MI; Kawase I
DNA Cell Biol; 2007 Mar; 26(3):178-85. PubMed ID: 17417946
[TBL] [Abstract][Full Text] [Related]
17. Endocytosis and intracellular trafficking of ErbBs.
Sorkin A; Goh LK
Exp Cell Res; 2009 Feb; 315(4):683-96. PubMed ID: 19278030
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor degradation: an alternative view of oncogenic pathways.
Kirisits A; Pils D; Krainer M
Int J Biochem Cell Biol; 2007; 39(12):2173-82. PubMed ID: 17855153
[TBL] [Abstract][Full Text] [Related]
19. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling.
Martin NP; Mohney RP; Dunn S; Das M; Scappini E; O'Bryan JP
Mol Pharmacol; 2006 Nov; 70(5):1643-53. PubMed ID: 16914641
[TBL] [Abstract][Full Text] [Related]
20. CSF-1 stimulated multiubiquitination of the CSF-1 receptor and of Cbl follows their tyrosine phosphorylation and association with other signaling proteins.
Wang Y; Yeung YG; Stanley ER
J Cell Biochem; 1999 Jan; 72(1):119-34. PubMed ID: 10025673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
